NCT04904588 2026-03-18ACCESSCenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting300 enrolled
NCT03126916 2026-02-27Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Children's Oncology GroupPhase 3 Recruiting750 enrolled
NCT06001385 2026-02-05OPTIMIZECenter for International Blood and Marrow Transplant ResearchPhase 2 Active not recruiting313 enrolled
NCT01175356 2026-01-23Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With IsotretinoinChildren's Oncology GroupPhase 1 Completed99 enrolled 11 charts